Deuterated momelotinib

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9776973
SERIAL NO

15364516

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention in one embodiment provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SUN PHARMACEUTICAL INDUSTRIES INC65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Silverman, Robert Arlington, US 15 346

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 3, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00